• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NLRP3 炎性体:IgA 肾病的致病作用及潜在治疗靶点。

NLRP3 inflammasome: Pathogenic role and potential therapeutic target for IgA nephropathy.

机构信息

Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, ROC.

Department of Biotechnology and Animal Science, National Ilan University, Ilan, Taiwan, ROC.

出版信息

Sci Rep. 2017 Jan 24;7:41123. doi: 10.1038/srep41123.

DOI:10.1038/srep41123
PMID:28117341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5259731/
Abstract

We have previously showed that IL-1β is involved in the pathogenesis of both spontaneously occurring and passively induced IgA nephropathy (IgAN) models. However, the exact causal-relationship between NLRP3 inflammasome and the pathogenesis of IgAN remains unknown. In the present study, we showed that [1] IgA immune complexes (ICs) activated NLRP3 inflammasome in macrophages involving disruption of mitochondrial integrity and induction of mitochondrial ROS, bone marrow-derived dendritic cells (BMDCs) and renal intrinsic cells; [2] knockout of NLRP3 inhibited IgA ICs-mediated activation of BMDCs and T cells; and [3] knockout of NLRP3 or a kidney-targeting delivery of shRNA of NLRP3 improved renal function and renal injury in a mouse IgAN model. These results strongly suggest that NLRP3 inflammasome serves as a key player in the pathogenesis of IgAN partly through activation of T cells and mitochondrial ROS production and that a local, kidney-targeting suppression of NLRP3 be a therapeutic strategy for IgAN.

摘要

我们之前已经表明,IL-1β 参与了自发发生和被动诱导的 IgA 肾病(IgAN)模型的发病机制。然而,NLRP3 炎性小体与 IgAN 发病机制之间的确切因果关系尚不清楚。在本研究中,我们表明:[1]IgA 免疫复合物(ICs)在巨噬细胞中激活 NLRP3 炎性小体,涉及线粒体完整性的破坏和诱导线粒体 ROS,骨髓来源的树突状细胞(BMDCs)和肾脏固有细胞;[2]NLRP3 敲除抑制 IgA ICs 介导的 BMDCs 和 T 细胞的激活;[3]NLRP3 敲除或 NLRP3 的肾脏靶向递送 shRNA 改善了 IgAN 小鼠模型的肾功能和肾脏损伤。这些结果强烈表明,NLRP3 炎性小体作为 IgAN 发病机制的关键参与者,部分通过激活 T 细胞和产生线粒体 ROS,而局部、肾脏靶向抑制 NLRP3 可能是 IgAN 的治疗策略。

相似文献

1
NLRP3 inflammasome: Pathogenic role and potential therapeutic target for IgA nephropathy.NLRP3 炎性体:IgA 肾病的致病作用及潜在治疗靶点。
Sci Rep. 2017 Jan 24;7:41123. doi: 10.1038/srep41123.
2
Tris DBA ameliorates IgA nephropathy by blunting the activating signal of NLRP3 inflammasome through SIRT1- and SIRT3-mediated autophagy induction.三羟甲基氨基甲烷二硫代氨基甲酸盐通过SIRT1和SIRT3介导的自噬诱导减弱NLRP3炎性小体的激活信号,从而改善IgA肾病。
J Cell Mol Med. 2020 Dec;24(23):13609-13622. doi: 10.1111/jcmm.15663. Epub 2020 Nov 1.
3
Antroquinonol mitigates an accelerated and progressive IgA nephropathy model in mice by activating the Nrf2 pathway and inhibiting T cells and NLRP3 inflammasome.antroquinonol通过激活Nrf2途径、抑制T细胞和NLRP3炎性小体减轻小鼠加速进展性IgA肾病模型。
Free Radic Biol Med. 2013 Aug;61:285-97. doi: 10.1016/j.freeradbiomed.2013.03.024. Epub 2013 Apr 6.
4
Mitochondrial reactive oxygen species-mediated NLRP3 inflammasome activation contributes to aldosterone-induced renal tubular cells injury.线粒体活性氧介导的NLRP3炎性小体激活促成醛固酮诱导的肾小管细胞损伤。
Oncotarget. 2016 Apr 5;7(14):17479-91. doi: 10.18632/oncotarget.8243.
5
Osthole mitigates progressive IgA nephropathy by inhibiting reactive oxygen species generation and NF-κB/NLRP3 pathway.蛇床子素通过抑制活性氧生成和 NF-κB/NLRP3 途径减轻进行性 IgA 肾病。
PLoS One. 2013 Oct 28;8(10):e77794. doi: 10.1371/journal.pone.0077794. eCollection 2013.
6
Oxidized phosphatidylcholine induces the activation of NLRP3 inflammasome in macrophages.氧化磷脂酰胆碱诱导巨噬细胞中NLRP3炎性小体的激活。
J Leukoc Biol. 2017 Jan;101(1):205-215. doi: 10.1189/jlb.3VMA1215-579RR. Epub 2016 Jun 2.
7
Inflammasome-Independent Role of NLRP3 Mediates Mitochondrial Regulation in Renal Injury.NLRP3 通过炎症小体非依赖机制调控肾脏损伤中线粒体功能。
Front Immunol. 2018 Nov 12;9:2563. doi: 10.3389/fimmu.2018.02563. eCollection 2018.
8
IgA Nephropathy Benefits from Compound K Treatment by Inhibiting NF-κB/NLRP3 Inflammasome and Enhancing Autophagy and SIRT1.中药单体化合物 K 通过抑制 NF-κB/NLRP3 炎症小体和增强自噬及 SIRT1 减轻 IgA 肾病
J Immunol. 2020 Jul 1;205(1):202-212. doi: 10.4049/jimmunol.1900284. Epub 2020 Jun 1.
9
Anti-dsDNA antibodies bind to TLR4 and activate NLRP3 inflammasome in lupus monocytes/macrophages.抗双链DNA抗体与Toll样受体4(TLR4)结合并激活狼疮单核细胞/巨噬细胞中的NLRP3炎性小体。
J Transl Med. 2016 Jun 1;14(1):156. doi: 10.1186/s12967-016-0911-z.
10
Galectin-3 contributes to pathogenesis of IgA nephropathy.半乳糖凝集素-3 有助于 IgA 肾病的发病机制。
Kidney Int. 2024 Oct;106(4):658-670. doi: 10.1016/j.kint.2024.06.023. Epub 2024 Jul 29.

引用本文的文献

1
Mechanisms of NLRP3 inflammasome in chronic kidney disease and the effects of traditional Chinese medicines.NLRP3炎性小体在慢性肾脏病中的作用机制及中药的影响
Ren Fail. 2025 Dec;47(1):2538798. doi: 10.1080/0886022X.2025.2538798. Epub 2025 Aug 21.
2
Hydroxychloroquine sulfate for IgA nephropathy: mechanisms and therapeutic potential in improving proteinuria and alleviating disease progression - a literature review.硫酸羟氯喹治疗IgA肾病:改善蛋白尿和缓解疾病进展的机制及治疗潜力——文献综述
BMC Nephrol. 2025 Jul 1;26(1):317. doi: 10.1186/s12882-025-04262-5.
3
Anti-Inflammatory Potential of Essential Oil from the Heart-Wood of the Folk Medicinal Tree Hayata in Macrophages.

本文引用的文献

1
NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages.NOX4 依赖性脂肪酸氧化促进巨噬细胞中 NLRP3 炎性小体的激活。
Nat Med. 2016 Sep;22(9):1002-12. doi: 10.1038/nm.4153. Epub 2016 Jul 25.
2
Poly-gamma-glutamic acid from Bacillus subtilis upregulates pro-inflammatory cytokines while inhibiting NLRP3, NLRC4 and AIM2 inflammasome activation.枯草芽孢杆菌聚谷氨酸上调促炎细胞因子,同时抑制 NLRP3、NLRC4 和 AIM2 炎性小体激活。
Cell Mol Immunol. 2018 Feb;15(2):111-119. doi: 10.1038/cmi.2016.13. Epub 2016 May 2.
3
NLRP3 Localizes to the Tubular Epithelium in Human Kidney and Correlates With Outcome in IgA Nephropathy.
民间药用植物恒春黄肉楠心材精油在巨噬细胞中的抗炎潜力
Int J Mol Sci. 2025 Jun 5;26(11):5419. doi: 10.3390/ijms26115419.
4
Multi-modal investigation reveals pathogenic features of diverse DDX3X missense mutations.多模态研究揭示了多种DDX3X错义突变的致病特征。
PLoS Genet. 2025 Jan 21;21(1):e1011555. doi: 10.1371/journal.pgen.1011555. eCollection 2025 Jan.
5
C-reactive protein promotes diabetic kidney disease via Smad3-mediated NLRP3 inflammasome activation.C反应蛋白通过Smad3介导的NLRP3炎性小体激活促进糖尿病肾病。
Mol Ther. 2025 Jan 8;33(1):263-278. doi: 10.1016/j.ymthe.2024.11.018. Epub 2024 Nov 13.
6
AIP1 Regulates Ocular Angiogenesis Via NLRP12-ASC-Caspase-8 Inflammasome-Mediated Endothelial Pyroptosis.AIP1通过NLRP12-ASC-半胱天冬酶-8炎性小体介导的内皮细胞焦亡调节眼部血管生成。
Adv Sci (Weinh). 2024 Dec;11(47):e2405834. doi: 10.1002/advs.202405834. Epub 2024 Nov 11.
7
A new era in the treatment of kidney diseases: NLRP3 inflammasome and cytokine-targeted therapies.肾脏病治疗的新时代:NLRP3炎性小体和细胞因子靶向疗法。
Pediatr Nephrol. 2025 May;40(5):1515-1521. doi: 10.1007/s00467-024-06578-0. Epub 2024 Nov 1.
8
Therapy Targeted to the NLRP3 Inflammasome in Chronic Kidney Disease.针对慢性肾脏病中NLRP3炎性小体的治疗
Kidney Dis (Basel). 2024 May 30;10(5):369-383. doi: 10.1159/000539496. eCollection 2024 Oct.
9
Ferroptosis-Related Genes in IgA Nephropathy: Screening for Potential Targets of the Mechanism.IgA肾病中与铁死亡相关的基因:机制潜在靶点的筛选
Int J Genomics. 2024 Aug 14;2024:8851124. doi: 10.1155/2024/8851124. eCollection 2024.
10
Renal macrophages and NLRP3 inflammasomes in kidney diseases and therapeutics.肾脏疾病与治疗中的肾巨噬细胞和NLRP3炎性小体
Cell Death Discov. 2024 May 13;10(1):229. doi: 10.1038/s41420-024-01996-3.
NLRP3定位于人肾脏的肾小管上皮细胞,且与IgA肾病的预后相关。
Sci Rep. 2016 Apr 20;6:24667. doi: 10.1038/srep24667.
4
Citral alleviates an accelerated and severe lupus nephritis model by inhibiting the activation signal of NLRP3 inflammasome and enhancing Nrf2 activation.柠檬醛通过抑制NLRP3炎性小体的激活信号并增强Nrf2激活来减轻加速性重症狼疮性肾炎模型。
Arthritis Res Ther. 2015 Nov 19;17:331. doi: 10.1186/s13075-015-0844-6.
5
The receptor NLRP3 is a transcriptional regulator of TH2 differentiation.受体 NLRP3 是 TH2 分化的转录调节因子。
Nat Immunol. 2015 Aug;16(8):859-70. doi: 10.1038/ni.3202. Epub 2015 Jun 22.
6
Xanthine oxidoreductase regulates macrophage IL1β secretion upon NLRP3 inflammasome activation.黄嘌呤氧化还原酶在NLRP3炎性小体激活后调节巨噬细胞白细胞介素1β的分泌。
Nat Commun. 2015 Mar 24;6:6555. doi: 10.1038/ncomms7555.
7
Cholera toxin, and the related nontoxic adjuvants mmCT and dmLT, promote human Th17 responses via cyclic AMP-protein kinase A and inflammasome-dependent IL-1 signaling.霍乱毒素以及相关的无毒佐剂mmCT和dmLT通过环磷酸腺苷 - 蛋白激酶A和炎性小体依赖性白细胞介素 - 1信号传导促进人类辅助性T细胞17(Th17)反应。
J Immunol. 2015 Apr 15;194(8):3829-39. doi: 10.4049/jimmunol.1401633. Epub 2015 Mar 18.
8
An NLRP3 inflammasome-triggered Th2-biased adaptive immune response promotes leishmaniasis.NLRP3炎性小体触发的偏向Th2的适应性免疫反应促进利什曼病。
J Clin Invest. 2015 Mar 2;125(3):1329-38. doi: 10.1172/JCI79526. Epub 2015 Feb 17.
9
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease.酮代谢产物β-羟基丁酸可阻断NLRP3炎性小体介导的炎性疾病。
Nat Med. 2015 Mar;21(3):263-9. doi: 10.1038/nm.3804. Epub 2015 Feb 16.
10
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.一种用于治疗炎症性疾病的NLRP3炎性小体小分子抑制剂。
Nat Med. 2015 Mar;21(3):248-55. doi: 10.1038/nm.3806. Epub 2015 Feb 16.